RNA Therapeutic for PMS | Phelan-McDermid Syndrome

PYC Therapeutics

This video provides an overview of phelan-mcdermid syndrome (PMS) and the mechanism of action (MoA) of PYC’s mRNA therapeutic candidate, PYC-002.

Previous
Previous

RNA Therapeutic for ADOA, Eye Disease / MoA / PYC Therapeutics

Next
Next

RNA Therapeutic for RP11 Eye Disease / MoA / PYC Therapeutics